HALO vs SGPYY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HALO · Halozyme Therapeutics$103.63 ▼ 15.72%
SGPYY · THE SAGE GROUP PLC UNSPON ADR EA REPR 4 ORD(POST REV SPLIT)$61.86 ▼ 3.76%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HALO +52.4%
- SGPYY +7.6%
Head to head
| Metric | HALO | SGPYY |
|---|---|---|
| Price | $103.63 | $61.86 |
| Change today | ▼ 15.72% | ▼ 3.76% |
| Market cap | $11.81B | $11.78B |
| Return, 3 months | +1.0% | +9.8% |
| Return, year to date | +54.0% | +8.9% |
| Return, 1 year | +51.9% | +8.7% |
| P/E (TTM) | 25.9 | 29.0 |
| P/B | -213.7 | 48.5 |
| P/E percentile vs own 5y | 79th | – |
| Dividend yield | – | 1.94% |
| Revenue growth (YoY, latest qtr) | +39.2% | – |
| Net profit growth (YoY) | +41.0% | – |
| Gross margin | 82.3% | – |
| Operating margin | 55.9% | – |
| Net margin | 26.9% | – |
| Return on equity | 216.4% | – |
| Analyst target vs. price | +25.2% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 29 | 56 |
| 30-day volatility | 60.5% | 33.4% |
| Max drawdown, 1 year | -24.1% | -31.8% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HALO is the largest of the group by market value.
- HALO has returned the most over the past year.
- HALO carries the lowest trailing P/E.
- SGPYY has been the calmest stock over the last 30 days.